Ariel Louwrier

Ariel Louwrier

Company: StressMarq Biosciences Inc.

Job title: President & CEO


President & CEO of StressMarq Biosciences Inc., a research reagent company with primary product lines in neurodegenerative diseases and cellular stress based in Victoria (BC), Canada. Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified success in moving technical businesses into new international arenas. Author of numerous peer-reviewed articles, and holder of several patents.


Examining the Effects of Sonication on Alpha Synuclein Pre-Formed Fibrils (PFFs) 11:50 am

• Alpha synuclein and tau pre-formed fibrils (PFFs) are useful tools for modelling neurodegenerative diseases. Various types can be generated with different properties • PFFs need to be sonicated prior to introducing them to cellular or animal models in order to generate disease pathology. This was originally thought to be because sonication reduces fibril length.…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.